Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Euro Surveill ; 29(27)2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38967014

RESUMEN

We describe an outbreak of Ralstonia pickettii in the United Kingdom, with isolates genetically indistinguishable from a 2023 Australian outbreak linked to internationally distributed saline solutions. Confirmed cases (n = 3) had bacteraemia, clinically relevant infection, indwelling venous lines and frequent healthcare contact. Multi-stakeholder intervention was required including product recall and risk communications. We recommend a low threshold for investigating clusters of Ralstonia species and similar opportunistic pathogens, considering contaminated product sources. Effective mitigation requires multi-agency partnership and international collaboration.


Asunto(s)
Brotes de Enfermedades , Infecciones por Bacterias Gramnegativas , Ralstonia pickettii , Humanos , Reino Unido/epidemiología , Ralstonia pickettii/aislamiento & purificación , Ralstonia pickettii/genética , Infecciones por Bacterias Gramnegativas/epidemiología , Infecciones por Bacterias Gramnegativas/microbiología , Solución Salina , Bacteriemia/epidemiología , Bacteriemia/microbiología , Australia/epidemiología , Contaminación de Medicamentos , Masculino
2.
J Hosp Infect ; 95(3): 245-252, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27658666

RESUMEN

BACKGROUND: Meticillin-resistant Staphylococcus aureus (MRSA) is frequently endemic in healthcare settings and may be transmitted by person-to-person spread. Asymptomatic MRSA carriers are potential, unsuspected sources for transmission and some of them may be identified by admission screening. AIM: To assess whether rapid point-of-care screening (POCS) for MRSA at hospital admission may be associated with a reduction in MRSA acquisition rates when compared with slower laboratory-based methods. METHODS: A cluster-randomized cross-over trial was conducted in four admission wards of an acute London tertiary care hospital. Polymerase chain reaction-based POCS screening was compared with conventional culture screening. Patients were screened on ward admission and discharge, and the MRSA acquisition rate on the admission wards was calculated as the primary outcome measure. RESULTS: In all, 10,017 patients were included; 4978 in the control arm, 5039 in the POCS arm. The MRSA carriage rate on admission was 1.7%. POCS reduced the median reporting time from 40.4 to 3.7 h (P < 0.001). MRSA was acquired on the admission wards by 23 (0.46%) patients in the control arm and by 24 (0.48%) in the intervention arm, acquisition rates of 5.39 and 4.60 per 1000 days respectively. After taking account of predefined confounding factors, the adjusted incidence rate ratio (IRR) for change in trend for MRSA acquisition was 0.961 (95% confidence interval: 0.766-1.206). The adjusted IRR for step change for MRSA acquisition was 0.98 (0.304-3.162). CONCLUSION: POCS produces a significantly faster result but has no effect on MRSA acquisition on admission wards compared with culture screening. Where compliance with infection prevention and control is high and MRSA carriage is low, POCS has no additional impact on MRSA acquisition rates over the first one to four days of admission compared with conventional culture screening.


Asunto(s)
Portador Sano/diagnóstico , Pruebas Diagnósticas de Rutina/métodos , Tamizaje Masivo/métodos , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Sistemas de Atención de Punto , Infecciones Estafilocócicas/diagnóstico , Adulto , Anciano , Técnicas Bacteriológicas/métodos , Portador Sano/microbiología , Estudios Cruzados , Femenino , Humanos , Londres , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Infecciones Estafilocócicas/microbiología , Centros de Atención Terciaria , Factores de Tiempo
3.
J Hosp Infect ; 63(4): 365-73, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16765481

RESUMEN

In 2001, the UK Department of Health introduced mandatory surveillance of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemias (blood-culture-positive episodes) in English hospitals. We performed enhanced surveillance in their hospital between April 2001 and March 2003 to determine the epidemiology of MRSA bacteraemia across different specialities. There were 267 MRSA-blood-culture-positive episodes, giving a rate of 0.37 per 1000 occupied bed-days (OBD). Thirty-three (12.4%) episodes were false positives due to contaminants and 15 (5.6%) originated in the community or at another institution. Thirty-one (11.6%) episodes were in outpatients or occurred after recent discharge and were designated 'hospital associated'. The remaining 188 cases were clinically significant hospital-acquired episodes in inpatients, with a rate of 0.26 per 1000 OBDs. The highest rates were in the intensive therapy unit (ITU; 2.74 per 1000 OBDs) and the high-dependency unit (HDU; 1.68 per 1000 OBDs). Fifty-five non-ITU, non-HDU episodes occurred in patients who had been discharged from ITU or HDU prior to the development of bacteraemia but during the same admission. The number of MRSA bacteraemias related to ITU/HDU suggests that these wards may be hubs of MRSA infection. Haematology, oncology and renal (HOR) patients had the greatest number of hospital-associated episodes. The most common source of MRSA bacteraemia was a vascular access device (VAD) (108 episodes, 57%, 64% of which were central lines). The high bacteraemia rates in ITU, HDU and HOR patients were associated with high usage of VADs. The majority of episodes occurred in patients who were newly colonized with MRSA after admission. Thus, in this hospital, VADs and stays in ITU or HDU are important risk factors for bacteraemia, and VAD care and prevention of cross-infection are priorities for intervention. We recommend that the mandatory national surveillance scheme should collect additional data on MRSA bacteraemia to provide information for a national strategy for MRSA control and to allow appropriate comparison between institutions.


Asunto(s)
Bacteriemia/epidemiología , Infección Hospitalaria/epidemiología , Resistencia a la Meticilina , Infecciones Estafilocócicas/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Bacteriemia/microbiología , Catéteres de Permanencia/microbiología , Niño , Preescolar , Femenino , Unidades Hospitalarias/estadística & datos numéricos , Hospitales de Enseñanza , Humanos , Lactante , Recién Nacido , Control de Infecciones , Londres/epidemiología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Staphylococcus aureus/efectos de los fármacos
4.
Am J Transplant ; 6(6): 1459-65, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16686771

RESUMEN

Two children, boys of 8 and 13 years, presented with measles-associated encephalopathy several years after kidney transplantation for congenital nephrotic syndrome. In the absence of prior clinical measles, the neurological symptoms initially eluded diagnosis, but retrospective analysis of stored samples facilitated the diagnosis of measles-associated encephalopathy without recourse to biopsy of deep cerebral lesions. Each had received a single dose of measles mumps and rubella vaccine before 12 months of age. Prior vaccination, reduction of immunosuppression and treatment with intravenous immunoglobulin and ribavirin may have contributed to their survival. Persistent measles virus RNA shedding, present in one child, was not controlled by treatment with i.v. ribavirin. Two years later, both patients continue to have functioning allografts with only minimal immunosuppression. These cases illustrate the difficulty in diagnosing measles-associated encephalopathy in the immunocompromised host, even in the era of molecular diagnostics, and highlight the renewed threat of neurological disease in communities with incomplete herd immunity.


Asunto(s)
Trasplante de Riñón/fisiología , Sarampión/complicaciones , Panencefalitis Esclerosante Subaguda/epidemiología , Adolescente , Biopsia , Encéfalo/patología , Niño , Humanos , Lactante , Vacuna contra el Sarampión-Parotiditis-Rubéola , Resultado del Tratamiento
5.
Arch Dis Child ; 91(6): 511-2, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16714723

RESUMEN

Community associated methicillin resistant Staphylococcus aureus (CA-MRSA) is an emerging pathogen typically associated with skin and soft tissue infection, with occasional reports of fatality in previously healthy children and young adults. We report a case of invasive CA-MRSA and highlight the potential impact of such infections on empirical treatment of staphylococcal infections.


Asunto(s)
Resistencia a la Meticilina , Fútbol/lesiones , Infecciones Estafilocócicas/transmisión , Staphylococcus aureus , Antibacterianos/uso terapéutico , Niño , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Infecciones Comunitarias Adquiridas/microbiología , Infecciones Comunitarias Adquiridas/transmisión , Quimioterapia Combinada , Genotipo , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Rifampin/uso terapéutico , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/genética , Staphylococcus aureus/aislamiento & purificación , Vancomicina/uso terapéutico
6.
J Stroke Cerebrovasc Dis ; 7(4): 263-4, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-17895095

RESUMEN

Uncontrollable crying following a left anterior choroidal artery infarction and responding to fluoxetine is described. It is possible that this region has a role in the regulation of emotion.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...